Skip to main content

Table 3 Breast cancer HER2 staining percentage by germline PV status

From: Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes

 

Case no. (N)

HER2−

HER2 + 

p value

BRCA1

56

55 (98.2%)

1 (1.8%)

0.000

BRCA2

60

57 (95.0%)

3 (5.0%)

0.001

PALB2

22

20 (90.9%)

2 (9.1%)

0.186

ATM

22

17 (77.3%)

5 (22.7%)

1.000

TP53

21

13 (61.9%)

8 (38.1%)

0.113

CHEK2

39

31 (79.5%)

8 (20.5%)

1.000

MMRs

18

11 (61.1%)

7 (38.9%)

0.146

PTEN

6

6 (100%)

0 (0.0%)

0.346

CDH1

3

3 (100%)

0 (0.0%)

1.000

Control/Reference

355

276 (77.7%)

79 (22.3%)